Os desafios da indústria farmacêutica no Brasil

Abstract

This paper evaluates the panorama of the Brazilian pharmaceutical industry thinking the implementation of the new technological standard. The hypothesis considered is that the difficulties in the implantation of the advanced industry in Brazil can weaken the national pharmaceutical sector, opening space for the development of new studies. Through a descriptive bibliographical survey will be presented a brief discussion of the innovative trajectory of the pharmaceutical sector, and advanced manufacturing, so that a relationship can be made between both. A parallel is established between the main global strategies and the actions promoted by Brazil for the implementation of industry 4.0, focusing on the measures directed to the health sector and consequent collection of relevant discussions. It will be shown why Brazil does not have a long-term national innovation strategy and the consequent loss to face the challenges posed by disruptive innovations.